Maximum quantity allowed is 999
Please select the quantity
CAS RN: 73590-58-6 | Product Number: O0359
Omeprazole
×
![]()
×
Purity: >98.0%(T)(HPLC)
Synonyms:
Product Documents:
| Size | Unit Price | Same Day | 2-3 Business Days |
|---|---|---|---|
| 5G |
$79.00
|
≥60 | 5 |
| 25G |
$279.00
|
7 | 14 |
* Please contact our distributors or
TCI
to order our products. The above prices do not include freight cost, customs, and other charges to the destination.
* The storage conditions are subject to change without notice.
| Product Number | O0359 |
| Purity / Analysis Method | >98.0%(T)(HPLC) |
| Molecular Formula / Molecular Weight | C__1__7H__1__9N__3O__3S = 345.42 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Refrigerated (0-10°C) |
| Store Under Inert Gas | Store under inert gas |
| Condition to Avoid | Light Sensitive,Air Sensitive,Heat Sensitive |
| CAS RN | 73590-58-6 |
| Reaxys Registry Number | 3628192 |
| PubChem Substance ID | 87560875 |
| Merck Index (14) | 6845 |
| MDL Number | MFCD00083192 |
Specifications
| Appearance | White to Light yellow powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(Nonaqueous Titration) | min. 98.0 % |
Properties (reference)
| Melting Point | 151 °C(dec.) |
| Solubility in water | Insoluble |
| Solubility (slightly sol. in) | Ethanol, Methanol |
| Solubility (insoluble in) | Ether |
GHS
Related Laws:
| RTECS# | DD9087000 |
Transport Information:
| H.S.code* | 2933.39-000 |
Application
Exosome research
Reference
- Effect of Proton Pump Inhibitor Pretreatment on Resistance of Solid Tumors to Cytotoxic Drugs
Application
最初に開発されたプロトンポンプ阻害剤 (PPI)，オメプラゾール
Omeprazole is the first proton pump inhibitor (PPI) that reduces gastric acid secretion. PPIs, such as omeprazole, lansoprazole [L0233], rabeprazole [R0115] and pantoprazole, are metabolized by cytochrome P 450 isoenzymes, 2C19 (CYP2C19) in the liver. The active (S)-enantiomer of omeprazole is esomeprazole. In additon, combinations of omeprazole as a PPI, amoxicillin [A2099], clarithromycin [C2220] and metronidazole [M0924] or another antibiotic have been reported to be effective in the treatment of Helicobacter pylori infection. Omeprazole is synthesized by the oxidation of omeprazole sulfide [O0437].
References
- Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome
- Omeprazole: the first proton pump inhibitor (a review)
- Omeprazole A review of its use in Helicobacter pylori infection, gastro-esophageal reflux disease and peptic ulcers induced by nonsteroidal anti-inflammatory drugs
- A proton-pump inhibitor expedition: the case histories of omeprazole and esomeprazole (a review)
- Pharmacogenomics of proton pump inhibitors (a review)
PubMed Literature
Articles/Brochures
TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.